• Published On : Aug-2016 |
  • Pages : 241 Pages |
  • Format :

1. Executive Summary

2. Assumptions and Acronyms

3. Research Methodology

4. Infectious Disease Diagnostics Market  Overview
   4.1.  Introduction
         4.1.1. Infectious Disease Diagnostics Market  Definition
         4.1.2. Infectious Disease Diagnostics Market  Taxonomy
   4.2.  Infectious Disease Diagnostics Market  Dynamics
         4.2.1. Drivers
         4.2.2. Restraints
         4.2.3. Opportunities 
         4.2.4. Trends 

5. Global Infectious Disease Diagnostics Market  Analysis, By Disease Indication 
   5.1.  Introduction
         5.1.1. Y-o-Y Growth Comparison, By Disease Indication 
         5.1.2. Market Share & Basis Point (BPS) Analysis, By Disease Indication 
   5.2.  Market Forecast, By Disease Indication 
         5.2.1. CNS Infection
                5.2.1.1. Absolute $ Opportunity
                5.2.1.2. Market Value (US$ Mn) Forecast
                5.2.1.3. Meningitis 
                5.2.1.4. Brain Abscess 
         5.2.2. Diarrheal Diseases 
                5.2.2.1. Absolute $ Opportunity
                5.2.2.2. Market Value (US$ Mn) Forecast
                5.2.2.3. Shigellosis 
                5.2.2.4. Cholera 
                5.2.2.5. Enteric/Typhoid Fever 
         5.2.3. Respiratory Infections 
                5.2.3.1. Absolute $ Opportunity
                5.2.3.2. Market Value (US$ Mn) Forecast
                5.2.3.3. Tuberculosis 
                5.2.3.4. Influenza
                5.2.3.5. Bronchitis 
         5.2.4. Blood Infections 
                5.2.4.1. Absolute $ Opportunity
                5.2.4.2. Market Value (US$ Mn) Forecast
                5.2.4.3. Malaria 
                5.2.4.4. Dengue 
                5.2.4.5. Infectious Mononucleosis 
                5.2.4.6. Others
         5.2.5. Sexually Transmitted Diseases 
                5.2.5.1. Absolute $ Opportunity
                5.2.5.2. Market Value (US$ Mn) Forecast
                5.2.5.3. Chlamydia 
                5.2.5.4. AIDS 
                5.2.5.5. Syphilis
                5.2.5.6. Others
   5.3.  Market Attractiveness Analysis, By Disease Indication

 
6. Global Infectious Disease Diagnostics Market  Analysis, By Technique 
   6.1.  Introduction
         6.1.1. Y-o-Y Growth Comparison, By Technique 
         6.1.2. Market Share & Basis Point (BPS) Analysis, By Technique 
   6.2.  Market Forecast, By Technique 
         6.2.1. ELISA 
                6.2.1.1. Absolute $ Opportunity
                6.2.1.2. Market Value (US$ Mn) Forecast
         6.2.2. Polymerase Chain Reaction
                6.2.2.1. Absolute $ Opportunity
                6.2.2.2. Market Value (US$ Mn) Forecast
         6.2.3. Immunoassays 
                6.2.3.1. Absolute $ Opportunity
                6.2.3.2. Market Value (US$ Mn) Forecast
         6.2.4. Cell Cultures 
                6.2.4.1. Absolute $ Opportunity
                6.2.4.2. Market Value (US$ Mn) Forecast
         6.2.5. Others 
                6.2.5.1. Absolute $ Opportunity
                6.2.5.2. Market Value (US$ Mn) Forecast
   6.3.  Market Attractiveness Analysis, By Technique

 7. Global Infectious Disease Diagnostics Market  Analysis, By End User 
   7.1.  Introduction
         7.1.1. Y-o-Y Growth Comparison, By End User 
         7.1.2. Market Share & Basis Point (BPS) Analysis, By End User 
   7.2.  Market Forecast, By End User 
         7.2.1. Hospitals
                7.2.1.1. Absolute $ Opportunity
                7.2.1.2. Market Value (US$ Mn) Forecast
         7.2.2. Diagnostic Centers
                7.2.2.1. Absolute $ Opportunity
                7.2.2.2. Market Value (US$ Mn) Forecast
         7.2.3. Clinics
                7.2.3.1. Absolute $ Opportunity
                7.2.3.2. Market Value (US$ Mn) Forecast
         7.2.4. Government Organisations
                7.2.4.1. Absolute $ Opportunity
                7.2.4.2. Market Value (US$ Mn) Forecast
   7.3.  Market Attractiveness Analysis, By End User 

8. Global Infectious Disease Diagnostics Market  Analysis, By Region
   8.1. Introduction
         8.1.1. Y-o-Y Growth Projections, By Region
         8.1.2. Market Share & Basis Point (BPS) Analysis, By Region
   8.2. Market Forecast, By Region
         8.2.1. North America Market Value (US$ Mn) Forecast
         8.2.2. Latin America  Market Value (US$ Mn) Forecast
         8.2.3. Europe Market Value (US$ Mn) Forecast
         8.2.4. APAC Market Value (US$ Mn) Forecast
         8.2.5. MEA Market Value (US$ Mn) Forecast
   8.3. Regional Attractiveness Analysis

9. North America Infectious Disease Diagnostics Market  Analysis
   9.1. Introduction
         9.1.1. Y-o-Y Growth Projections, By Country
         9.1.2. Market Share & Basis Point (BPS) Analysis, By Country
   9.2. Key Trends
   9.3. North America Market Forecast
         9.3.1. Market Value (US$ Mn) Forecast, By Country
                9.3.1.1. U.S. Absolute $ Opportunity
                9.3.1.2. Canada Absolute $ Opportunity
         9.3.2. Market Value (US$ Mn) Forecast, By Disease Indication 
                9.3.2.1. CNS Infection
                          9.3.2.1.1. Meningitis 
                          9.3.2.1.2. Brain Abscess 
                9.3.2.2. Diarrheal Diseases 
                          9.3.2.2.1. Shigellosis 
                          9.3.2.2.2. Cholera 
                          9.3.2.2.3. Typhoid Fever 
                9.3.2.3. Respiratory Infections 
                          9.3.2.3.1. Tuberculosis 
                          9.3.2.3.2. Influenza
                          9.3.2.3.3. Bronchitis 
                9.3.2.4. Blood Infections 
                          9.3.2.4.1. Malaria 
                          9.3.2.4.2. Dengue 
                          9.3.2.4.3. Infectious Mononucleosis 
                          9.3.2.4.4. Others
                9.3.2.5. Sexually Transmitted Diseases 
                          9.3.2.5.1. Chlamydia 
                          9.3.2.5.2. AIDS 
                          9.3.2.5.3. Syphilis
                          9.3.2.5.4. Others
         9.3.3. Market Value (US$ Mn) Forecast, By End User 
                9.3.3.1. Hospitals
                9.3.3.2. Diagnostic Centers
                9.3.3.3. Clinics
                9.3.3.3. Government Organisations
         9.3.4. Market Value (US$ Mn) Forecast, By Technique  
                9.3.4.1. ELISA 
                9.3.4.2. Polymerase Chain Reaction
                9.3.4.3. Immunoassays 
                9.3.4.4. Cell Cultures 
                9.3.4.5. Others 
   9.4. Market Attractiveness Analysis
         9.4.1. By Country
         9.4.2. By Disease Indication 
         9.4.3. By Technique 
         9.4.4. By End User 

10. Latin America  Infectious Disease Diagnostics Market  Analysis
   10.1. Introduction
         10.1.1. Y-o-Y Growth Projections, By Country
         10.1.2. Market Share & Basis Point (BPS) Analysis, By Country
   10.2. Key Trends
   10.3. Latin America  Market Forecast
         10.3.1. Market Value (US$ Mn) Forecast, By Country
                10.3.1.1. Brazil Absolute $ Opportunity
                10.3.1.2. Mexico Absolute $ Opportunity
                10.3.1.3. Rest of Latin America Absolute $ Opportunity
         10.3.2. Market Value (US$ Mn) Forecast, By Disease Indication 
                10.3.2.1. CNS Infection
                          10.3.2.1.1. Meningitis 
                          10.3.2.1.2. Brain Abscess 
                10.3.2.2. Diarrheal Diseases 
                          10.3.2.2.1. Shigellosis 
                          10.3.2.2.2. Cholera 
                          10.3.2.2.3. Typhoid Fever 
                10.3.2.3. Respiratory Infections 
                          10.3.2.3.1. Tuberculosis 
                          10.3.2.3.2. Influenza
                          10.3.2.3.3. Bronchitis 
                10.3.2.4. Blood Infections 
                          10.3.2.4.1. Malaria 
                          10.3.2.4.2. Dengue 
                          10.3.2.4.3. Infectious Mononucleosis 
                          10.3.2.4.4. Others
                10.3.2.5. Sexually Transmitted Diseases 
                          10.3.2.5.1. Chlamydia 
                          10.3.2.5.2. AIDS 
                          10.3.2.5.3. Syphilis
                          10.3.2.5.4. Others
         10.3.3. Market Value (US$ Mn) Forecast, By End User 
                10.3.3.1. Hospitals
                10.3.3.2. Diagnostic Centers
                10.3.3.3. Clinics
                10.3.3.4. Government Organisations
         10.3.4. Market Value (US$ Mn) Forecast, By Technique  
                10.3.4.1. ELISA 
                10.3.4.2. Polymerase Chain Reaction
                10.3.4.3. Immunoassays 
                10.3.4.4. Cell Cultures 
                10.3.4.5. Others 
   10.4. Market Attractiveness Analysis
         10.4.1. By Country
         10.4.2. By Disease Indication 
         10.4.3. By Technique 
         10.4.4. By End User 

11. Europe Infectious Disease Diagnostics Market  Analysis
   11.1. Introduction
         11.1.1. Y-o-Y Growth Projections, By Country
         11.1.2. Market Share & Basis Point (BPS) Analysis, By Country
   11.2. Key Trends
   11.3. Europe Market Forecast
         11.3.1. Market Value (US$ Mn) Forecast, By Country
                11.3.1.1. U.K. Absolute $ Opportunity
                11.3.1.2. Germany Absolute $ Opportunity
                11.3.1.3. Italy Absolute $ Opportunity
                11.3.1.4. France Absolute $ Opportunity
                11.3.1.5. Spain Absolute $ Opportunity
                11.3.1.6. Rest of Europe Absolute $ Opportunity
         11.3.2. Market Value (US$ Mn) Forecast, By Disease Indication 
                11.3.2.1. CNS Infection
                          11.3.2.1.1. Meningitis 
                          11.3.2.1.2. Brain Abscess 
                11.3.2.2. Diarrheal Diseases 
                          11.3.2.2.1. Shigellosis 
                          11.3.2.2.2. Cholera 
                          11.3.2.2.3. Typhoid Fever 
                11.3.2.3. Respiratory Infections 
                          11.3.2.3.1. Tuberculosis 
                          11.3.2.3.2. Influenza
                          11.3.2.3.3. Bronchitis 
                11.3.2.4. Blood Infections 
                          11.3.2.4.1. Malaria 
                          11.3.2.4.2. Dengue 
                          11.3.2.4.3. Infectious Mononucleosis 
                          11.3.2.4.4. Others
                11.3.2.5. Sexually Transmitted Diseases 
                          11.3.2.5.1. Chlamydia 
                          11.3.2.5.2. AIDS 
                          11.3.2.5.3. Syphilis
                          11.3.2.5.4. Others
         11.3.3. Market Value (US$ Mn) Forecast, By End User 
                11.3.3.1. Hospitals
                11.3.3.2. Diagnostic Centers
                11.3.3.3. Clinics
                11.3.3.4. Government Organisations
         11.3.4. Market Value (US$ Mn) Forecast, By Technique  
                11.3.4.1. ELISA 
                11.3.4.2. Polymerase Chain Reaction
                11.3.4.3. Immunoassays 
                11.3.4.4. Cell Cultures 
                11.3.4.5. Others 
   11.4. Market Attractiveness Analysis
         11.4.1. By Country
         11.4.2. By Disease Indication 
         11.4.3. By Technique 
         11.4.4. By End User 

12. APAC Infectious Disease Diagnostics Market  Analysis
   12.1. Introduction
         12.1.1. Y-o-Y Growth Projections, By Country
         12.1.2. Market Share & Basis Point (BPS) Analysis, By Country
   12.2. Key Trends
   12.3. APAC Market Forecast
         12.3.1. Market Value (US$ Mn) Forecast, By Country
                12.3.1.1. China  Absolute $ Opportunity
                12.3.1.2. India Absolute $ Opportunity
                12.3.1.3. Japan Absolute $ Opportunity
                12.3.1.4. Australia & New Zealand Absolute $ Opportunity
                12.3.1.5. Rest of APAC Absolute $ Opportunity
         12.3.2. Market Value (US$ Mn) Forecast, By Disease Indication 
                12.3.2.1. CNS Infection
                          12.3.2.1.1. Meningitis 
                          12.3.2.1.2. Brain Abscess 
                12.3.2.2. Diarrheal Diseases 
                          12.3.2.2.1. Shigellosis 
                          12.3.2.2.2. Cholera 
                          12.3.2.2.3. Typhoid Fever 
                12.3.2.3. Respiratory Infections 
                          12.3.2.3.1. Tuberculosis 
                          12.3.2.3.2. Influenza
                          12.3.2.3.3. Bronchitis 
                12.3.2.4. Blood Infections 
                          12.3.2.4.1. Malaria 
                          12.3.2.4.2. Dengue 
                          12.3.2.4.3. Infectious Mononucleosis 
                          12.3.2.4.4. Others
                12.3.2.5. Sexually Transmitted Diseases 
                          12.3.2.5.1. Chlamydia 
                          12.4.2.5.2. AIDS 
                          12.4.2.5.3. Syphilis
                          12.4.2.5.4. Others
         12.3.3. Market Value (US$ Mn) Forecast, By End User 
                12.3.3.1. Hospitals
                12.3.3.2. Diagnostic Centers
                12.3.3.3. Clinics
                12.3.3.4. Government Organisations
         12.3.4. Market Value (US$ Mn) Forecast, By Technique  
                12.3.4.1. ELISA 
                12.3.4.2. Polymerase Chain Reaction
                12.3.4.3. Immunoassays 
                12.3.4.4. Cell Cultures 
                12.3.4.5. Others 
   12.4. Market Attractiveness Analysis
         12.4.1. By Country
         12.4.2. By Disease Indication 
         12.4.3. By Technique 
         12.4.4. By End User 

13. MEA Infectious Disease Diagnostics Market  Analysis
   13.1. Introduction
         13.1.1. Y-o-Y Growth Projections, By Country
         13.1.2. Market Share & Basis Point (BPS) Analysis, By Country
   13.2. Key Trends
   13.3. MEA Market Forecast
         13.3.1. Market Value (US$ Mn) Forecast, By Country
                13.3.2.1. GCC Countries Absolute $ Opportunity
                13.3.2.2. South Africa Absolute $ Opportunity
                13.3.2.3. Rest of MEA  Absolute $ Opportunity
         13.3.2. Market Vlue (US$ Mn) Forecast, By Disease Indication 
                13.3.2.1. CNS Infection
                          13.3.2.1.1. Meningitis 
                          13.3.2.1.2. Brain Abscess 
                13.3.2.2. Diarrheal Diseases 
                          13.3.2.2.1. Shigellosis 
                          13.3.2.2.2. Cholera 
                          13.3.2.2.3. Typhoid Fever 
                13.3.2.3. Respiratory Infections 
                          13.3.2.3.1 Tuberculosis 
                          13.3.2.3.2. Influenza
                          13.3.2.3.3. Bronchitis 
                13.3.2.4. Blood Infections 
                          13.3.2.4.1. Malaria 
                          13.3.2.4.2. Dengue 
                          13.3.2.4.3. Infectious Mononucleosis 
                          13.3.2.4.4. Others
                13.3.2.5. Sexually Transmitted Diseases 
                          13.3.2.5.1.  Chlamydia 
                          13.3.2.5.2. AIDS 
                          13.3.2.5.3.  Syphilis
                          13.3.2.5.4. Others
         13.3.3. Market Value (US$ Mn) Forecast, By End User 
                13.3.3.1. Hospitals
                13.3.3.2. Diagnostic Centers
                13.3.3.3. Clinics
                13.3.3.4. Government Organisations
         13.4.4. Market Value (US$ Mn) Forecast, By 
         13.4.5. Market Value (US$ Mn) Forecast, By Technique  
                13.4.5.1. ELISA 
                13.4.5.2. Polymerase Chain Reaction
                13.4.5.3. Immunoassays 
                13.4.5.4. Cell Cultures 
                13.4.5.5. Others 
   13.4. Market Attractiveness Analysis
         13.4.1. By Country
         13.4.2. By Disease Indication 
         13.4.3. By Technique 
         13.4.4. By End User 

14.  Competition Landscape
   14.1.  Competition Dashboard
   14.2.  Company Share Analysis
   14.3.  Company Profiles
         14.3.1. Revenue
         14.3.2. Products/Brand Offerings
         14.3.3. Key developments
         14.3.4. SWOT Analysis
   14.4.  Company Profiled
         14.4.1. Becton Dickinson & Company
         14.4.2. Cepheid, Inc.
         14.4.4. Abbott Laboratories 
         14.4.4. bioMerieux SA
         14.4.5. Hologic, Inc.
         14.4.6. Danaher Corporation
         14.4.7. Thermo Fisher Scientific, Inc.
         14.4.8. Roche Diagnostics
         14.4.9. Alera Inc.
         14.4.9. DiaSorin S.p.A.
         14.4.11. Quidel Corporation 
         14.4.12. Bio-Rad Laboratories, Inc.


List of Tables

Table 01: Global Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By End User, 2016–2024
Table 02: Global Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By Disease Indication, 2016–2024
Table 03: Global Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By CNS Infection Disease Indication Segment, 2016–2024
Table 04: Global Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By Diarrhoeal Disease Indication Segment, 2016–2024
Table: 05 Global Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By Respiratory Infections Disease Indication Segment, 2016–2024
Table 06: Global Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By Blood Infections Disease Indication Segment, 2016–2024
Table 07: Global Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By STDs Disease Indication Segment, 2016–2024
Table 08: Global Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By Technique, 2016–2024
Table 09: Global Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By Region, 2016–2024
Table 10: North America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By Country, 2016–2024
Table 11: North America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By Disease Indication, 2016–2024
Table 12: North America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By CNS Infection Disease Indication Segment, 2016–2024
Table 13: North America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By Diarrhoeal Disease Indication Segment, 2016–2024
Table 14: North America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By Respiratory Infections Disease Indication Segment, 2016–2024
Table 15: North America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By Blood Infections Disease Indication Segment, 2016–2024
Table 16: North America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By STDs Disease Indication Segment, 2016–2024
Table 17: North America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By Technique, 2016–2024
Table 18: North America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast By End User, 2016–2024
Table 19: Latin America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Country, 2016–2024
Table 20: Latin America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Disease Indication, 2016–2024
Table 21: Latin America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By CNS Infection Disease Indication Segment, 2016–2024
Table 22: Latin America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Diarrhoeal Disease Indication Segment, 2016–2024
Table 23: Latin America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Respiratory Infections Disease Indication Segment, 2016–2024
Table 24: Latin America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Blood Infections Disease Indication Segment, 2016–2024
Table 25: Latin America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By STDs Disease Indication Segment, 2016–2024
Table 26: Latin America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Technique, 2016–2024
Table 27: Latin America Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By End User, 2016–2024
Table 28: Europe Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Country, 2016–2024
Table 29: Europe Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Disease Indication, 2016–2024
Table 30: Europe Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By CNS Infection Disease Indication Segment, 2016–2024
Table 31: Europe Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Diarrhoeal Disease Indication Segment, 2016–2024
Table 32: Europe Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Respiratory Infections Disease Indication Segment, 2016–2024
Table 33: Europe Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Blood Infections Disease Indication Segment, 2016–2024
Table 34: Europe Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By STDs Disease Indication Segment, 2016–2024
Table 35: Europe Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Technique, 2016–2024
Table 36: Europe Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By End User, 2016–2024
Table 37: APAC Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Country, 2016–2024
Table 38: APAC Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Disease Indication, 2016–2024
Table 39: APAC Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By CNS Infection Disease Indication Segment, 2016–2024
Table 40: APAC Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Diarrhoeal Disease Indication Segment, 2016–2024
Table 41: APAC Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Respiratory Infections Disease Indication Segment, 2016–2024
Table 42: APAC Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Blood Infections Disease Indication Segment, 2016–2024
Table 43: APAC Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By STDs Disease Indication Segment, 2016–2024
Table 44: APAC Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Technique, 2016–2024
Table 45: APAC Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By End User, 2016–2024
Table 46: MEA Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Country, 2016–2024
Table 47: MEA Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Disease Indication, 2016–2024
Table 48: MEA Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By CNS Infection Disease Indication Segment, 2016–2024
Table 49: MEA Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Diarrhoeal Disease Indication Segment, 2016–2024
Table 50: MEA Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Respiratory Infections Disease Indication Segment, 2016–2024
Table 51: MEA Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Blood Infections Disease Indication Segment, 2016–2024
Table 52: MEA Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By STDs Disease Indication Segment, 2016–2024
Table 53: MEA Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By Technique, 2016–2024
Table 54: MEA Infectious Disease Diagnostics Market Value (US$ Mn) and Forecast, By End User, 2016–2024


List of Figures 

Figure 01: Global Infectious Disease Diagnostics Market – Scenario Forecast, 2015–2024 (US$ Mn)
Figure 02: Global Infectious Disease Diagnostics Market Share Analysis (%) By Disease Indication, 2016–2024   
Figure 03: Global Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Disease Indication, 2016–2024 
Figure 04: Global Infectious Disease Diagnostics Market Attractiveness Analysis, By Disease Indication, 2016–2024
Figure 05: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Disease Indication, 2016–2024
Figure 06: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Disease Indication, 2016–2024
Figure 07: Global Infectious Disease Diagnostics Market Share Analysis (%) By CNS Infections, 2016–2024  
Figure 08: Global Infectious Disease Diagnostics Market Y-o-Y Growth (%) By CNS Infections, 2016–2024 
Figure 09: Global Infectious Disease Diagnostics Market Attractiveness Analysis By CNS Infection Segment, 2016–2024
Figure 10: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By CNS Infection Segment, 2016–2024
Figure 11: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By CNS Infection Segment, 2016–2024
Figure 12: Global Infectious Disease Diagnostics Market Share Analysis (%) By Diarrheal Infection Segment, 2016–2024  
Figure13: Global Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Diarrheal Infection Segment, 2016–2024 
Figure 14: Global Infectious Disease Diagnostics Market Attractiveness Analysis By Diarrheal Infection Segment, 2016–2024
Figure 15: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Diarrheal Infection Segment, 2016–2024
Figure 16: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Diarrheal Infection Segment, 2016–2024
Figure 17: Global Infectious Disease Diagnostics Market Share Analysis (%) By Respiratory Infection Segment, 2016–2024  
Figure 18: Global Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Respiratory Infection Segment, 2016–2024 
Figure 19: Global Infectious Disease Diagnostics Market Attractiveness Analysis By Respiratory Infection Segment, 2016–2024
Figure 20: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Respiratory Infection Segment, 2016–2024
Figure 21: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Respiratory Infection Segment, 2016–2024
Figure 22: Global Infectious Disease Diagnostics Market Share Analysis (%) By Blood Infection Segment, 2016–2024  
Figure 23: Global Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Blood Infection Segment, 2016–2024 
Figure 24: Global Infectious Disease Diagnostics Market Attractiveness Analysis By Blood Infection Segment, 2016–2024
Figure 25: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Blood Infection Segment, 2016–2024
Figure 26: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Blood Infection Segment, 2016–2024
Figure 27: Global Infectious Disease Diagnostics Market Share Analysis (%) By STDs Segment, 2016–2024    
Figure 28: Global Infectious Disease Diagnostics Market Y-o-Y Growth (%) By STDs Segment, 2016–2024   
Figure 29: Global Infectious Disease Diagnostics Market Attractiveness Analysis By STDs Segment, 2016–2024  
Figure 30: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By STDs Segment, 2016–2024  
Figure 31: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By STDs Segment, 2016–2024  
Figure 32: Global Infectious Disease Diagnostics Market Share Analysis (%) By Technique, 2016–2024  
Figure 33: Global Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Technique, 2016–2024 
Figure 34: Global Infectious Disease Diagnostics Market Attractiveness Analysis Technique, 2016–2024
Figure 35: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Cell Cultures Technique Segment, 2016–2024
Figure 36: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Cell Cultures Technique Segment, 2016–2024
Figure 37: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Immunoassays Technique Segment, 2016–2024
Figure 38: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Immunoassays Technique Segment, 2016–2024
Figure 39: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By ELISA Technique Segment, 2016–2024
Figure 40: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By ELISA Technique Segment, 2016–2024
Figure 41: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By PCR Technique Segment, 2016–2024
Figure 42: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By PCR Technique Segment, 2016–2024
Figure 43: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Others Technique Segment, 2016–2024
Figure 44: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Others Technique Segment, 2016–2024
Figure 45: Global Infectious Disease Diagnostics Market Share Analysis (%) By End User, 2016–2024  
Figure 46: Global Infectious Disease Diagnostics Market Y-o-Y Growth (%) By End User, 2016–2024 
Figure 47: Global Infectious Disease Diagnostics Market Attractiveness Analysis, By End User, 2016–2024
Figure 48: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Hospitals End User Segment, 2016–2024
Figure 49: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Hospitals End User Segment, 2016–2024
Figure 50: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Diagnostic Centers End User Segment, 2016–2024
Figure 51: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Diagnostic Centers End User Segment, 2016–2024
Figure 52: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Clinics End User Segment, 2016–2024
Figure 53: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Clinics End User Segment, 2016–2024
Figure 54: Global Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Government Organizations End User Segment, 2016–2024
Figure 55: Global Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Government Organizations End User Segment, 2016–2024
Figure 56: Infectious Disease Diagnostics Market Value (US$ Mn) and CAGR (%) By Region, 2015, 2020, and 2024
Figure 57: Global Infectious Disease Diagnostics Market Share Analysis (%) By Region, 2016–2024  
Figure 58: Global Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Region, 2016–2024 
Figure 59: Global Infectious Disease Diagnostics Market Attractiveness Analysis By Region, 2016–2024
Figure 60: North America Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn), 2016–2024
Figure 61: North America Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 62: Latin America Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn), 2016–2024
Figure 63: Latin America Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 64: Europe Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn), 2016–2024
Figure 65: Europe Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 66: APAC Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn), 2016–2024
Figure 67: APAC Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 68: MEA Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn), 2016–2024
Figure 69: MEA Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 70: North America Infectious Disease Diagnostics Market Share Analysis (%) By Disease Indication, 2016–2024  
Figure 71: North America Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Disease Indication, 2016–2024 
Figure 72: North America Infectious Disease Diagnostics Market Share Analysis (%) By Country, 2016–2024  
Figure 73: North America Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Country, 2016–2024 
Figure 74: North America Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By U.S., 2016–2024
Figure 75: North America Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By U.S., 2016–2024
Figure 76: North America Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Canada, 2016–2024
Figure 77: North America Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Canada, 2016–2024
Figure 78: North America Infectious Disease Diagnostics Market Attractiveness Analysis, By Country, 2016–2024
Figure 79: North America Infectious Disease Diagnostics Market Attractiveness Analysis, By Disease Indication, 2016–2024
Figure 80: North America Infectious Disease Diagnostics Market Attractiveness Analysis, By Technique, 2016–2024
Figure 81: North America Infectious Disease Diagnostics Market Attractiveness Analysis, By End User, 2016–2024
Figure 82: Latin America Infectious Disease Diagnostics Market Share Analysis (%) By Disease Indication, 2016–2024  
Figure 83: Latin America Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Disease Indication, 2016–2024 
Figure 84: Latin America Infectious Disease Diagnostics Market Share Analysis (%) By Country, 2016–2024  
Figure 85: Latin America Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Country, 2016–2024 
Figure 86: Latin America Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Brazil, 2016–2024
Figure 87: Latin America Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Brazil, 2016–2024
Figure 88: Latin America Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Mexico, 2016–2024
Figure 89: Latin America Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Mexico, 2016–2024
Figure 90: Latin America Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Argentina, 2016–2024
Figure 91: Latin America Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Argentina, 2016–2024
Figure 92: Latin America Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Rest of Latin America, 2016–2024
Figure 93: Latin America Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Rest of Latin America, 2016–2024
Figure 94: Latin America Infectious Disease Diagnostics Market Attractiveness Analysis, By Country, 2016–2024
Figure 95: Latin America Infectious Disease Diagnostics Market Attractiveness Analysis, By Disease Indication, 2016–2024
Figure 96: Latin America Infectious Disease Diagnostics Market Attractiveness Analysis, By Technique, 2016–2024
Figure 97: Latin America Infectious Disease Diagnostics Market Attractiveness Analysis, By End User, 2016–2024
Figure 98: Europe Infectious Disease Diagnostics Market Share Analysis (%) By Disease Indication, 2016–2024  
Figure 99: Europe Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Disease Indication, 2016–2024 
Figure 100: Europe Infectious Disease Diagnostics Market Share Analysis (%) By Country, 2016–2024  
Figure 101: Europe Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Country, 2016–2024 
Figure 102: Europe Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By The U.K., 2016–2024
Figure 103: Europe Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By The U.K., 2016–2024
Figure 104: Europe Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Germany, 2016–2024
Figure 105: Europe Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Germany, 2016–2024
Figure 106: Europe Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By France, 2016–2024
Figure 107: Europe Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By France, 2016–2024
Figure 108: Europe Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Italy, 2016–2024
Figure 109: Europe Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Italy, 2016–2024
Figure 110: Europe Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Spain, 2016–2024
Figure 111: Europe Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Spain, 2016–2024
Figure 112: Europe Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Rest of Europe, 2016–2024
Figure 113: Europe Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Rest of Europe, 2016–2024
Figure 114: Europe Infectious Disease Diagnostics Market Attractiveness Analysis, By Country, 2016–2024
Figure 115: Europe Infectious Disease Diagnostics Market Attractiveness Analysis, By Disease Indication, 2016–2024
Figure 116: Europe Infectious Disease Diagnostics Market Attractiveness Analysis, By Technique, 2016–2024
Figure 117: Europe Infectious Disease Diagnostics Market Attractiveness Analysis, By End User, 2016–2024
Figure 118: APAC Infectious Disease Diagnostics Market Share Analysis (%) By Disease Indication, 2016–2024  
Figure 119: APAC Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Disease Indication, 2016–2024 
Figure 120: APAC Infectious Disease Diagnostics Market Share Analysis (%) By Country, 2016–2024  
Figure 121: APAC Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Country, 2016–2024 
Figure 122: APAC Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By China, 2016–2024
Figure 123: APAC Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By China, 2016–2024
Figure 124: APAC Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Japan, 2016–2024
Figure 125: APAC Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Japan, 2016–2024
Figure 126: APAC Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By India, 2016–2024
Figure 127: APAC Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By India, 2016–2024
Figure 128: APAC Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Australia & New Zealand, 2016–2024
Figure 129: APAC Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Australia & New Zealand, 2016–2024
Figure 130: APAC Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Rest of APAC, 2016–2024
Figure 131: APAC Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Rest of APAC, 2016–2024
Figure 133: APAC Infectious Disease Diagnostics Market Attractiveness Analysis, By Disease Indication, 2016–2024
Figure 134: APAC Infectious Disease Diagnostics Market Attractiveness Analysis, By Technique, 2016–2024
Figure 135: APAC Infectious Disease Diagnostics Market Attractiveness Analysis, By End User, 2016–2024
Figure 136: MEA Infectious Disease Diagnostics Market Share Analysis (%) By Disease Indication, 2016–2024  
Figure 137: MEA Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Disease Indication, 2016–2024 
Figure 138: MEA Infectious Disease Diagnostics Market Share Analysis (%) By Country, 2016–2024  
Figure 139: MEA Infectious Disease Diagnostics Market Y-o-Y Growth (%) By Country, 2016–2024 
Figure 140: MEA Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By GCC Countries, 2016–2024
Figure 141: MEA Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By GCC Countries, 2016–2024
Figure 142: MEA Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By South Africa, 2016–2024
Figure 143: MEA Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By South Africa, 2016–2024
Figure 144: MEA Infectious Disease Diagnostics Market Revenue Analysis (US$ Mn) By Rest of MEA, 2016–2024
Figure 145: MEA Infectious Disease Diagnostics Market Absolute $ Opportunity (US$ Mn) By Rest of MEA, 2016–2024
Figure 146: MEA Infectious Disease Diagnostics Market Attractiveness Analysis, By Country, 2016–2024
Figure 147: MEA Infectious Disease Diagnostics Market Attractiveness Analysis, By Disease Indication, 2016–2024
Figure 148: MEA Infectious Disease Diagnostics Market Attractiveness Analysis, By Technique, 2016–2024
Figure 149: MEA Infectious Disease Diagnostics Market Attractiveness Analysis, By End User, 2016–2024
Figure 150: Market Share of Prominent Key Players: Infectious Diseases Market, 2015